Southern Acids (M) Berhad (KLSE: SAB)

Southern Acids (M) Berhad Statistics

Total Valuation

Southern Acids (M) Berhad has a market cap or net worth of MYR 438.19 million. The enterprise value is 179.18 million.

Market Cap	438.19M
Enterprise Value	179.18M

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	Oct 17, 2024

Share Statistics

Southern Acids (M) Berhad has 136.93 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	136.93M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.16%
Owned by Institutions (%)	11.31%
Float	37.07M

Valuation Ratios

The trailing PE ratio is 70.88.

PE Ratio	70.88
Forward PE	n/a
PS Ratio	0.46
PB Ratio	0.57
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.96, with an EV/FCF ratio of -13.17.

EV / Earnings	28.98
EV / Sales	0.19
EV / EBITDA	2.96
EV / EBIT	5.13
EV / FCF	-13.17

Financial Position

The company has a current ratio of 5.61, with a Debt / Equity ratio of 0.03.

Current Ratio	5.61
Quick Ratio	4.71
Debt / Equity	0.03
Debt / EBITDA	0.40
Debt / FCF	-1.77
Interest Coverage	41.19

Financial Efficiency

Return on equity (ROE) is 1.80% and return on invested capital (ROIC) is 2.45%.

Return on Equity (ROE)	1.80%
Return on Assets (ROA)	2.18%
Return on Capital (ROIC)	2.45%
Revenue Per Employee	542,081
Profits Per Employee	3,543
Employee Count	1,745
Asset Turnover	0.93
Inventory Turnover	7.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-1.84%
50-Day Moving Average	3.21
200-Day Moving Average	3.29
Relative Strength Index (RSI)	53.63
Average Volume (20 Days)	11,485

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Southern Acids (M) Berhad had revenue of MYR 945.93 million and earned 6.18 million in profits. Earnings per share was 0.05.

Revenue	945.93M
Gross Profit	190.35M
Operating Income	35.35M
Pretax Income	34.10M
Net Income	6.18M
EBITDA	59.45M
EBIT	35.35M
Earnings Per Share (EPS)	0.05

Balance Sheet

The company has 381.40 million in cash and 24.04 million in debt, giving a net cash position of 357.35 million or 2.61 per share.

Cash & Cash Equivalents	381.40M
Total Debt	24.04M
Net Cash	357.35M
Net Cash Per Share	2.61
Equity (Book Value)	870.92M
Book Value Per Share	5.64
Working Capital	504.44M

Cash Flow

In the last 12 months, operating cash flow was 22.76 million and capital expenditures -36.36 million, giving a free cash flow of -13.61 million.

Operating Cash Flow	22.76M
Capital Expenditures	-36.36M
Free Cash Flow	-13.61M
FCF Per Share	-0.10

Margins

Gross margin is 20.12%, with operating and profit margins of 3.74% and 0.65%.

Gross Margin	20.12%
Operating Margin	3.74%
Pretax Margin	3.61%
Profit Margin	0.65%
EBITDA Margin	6.28%
EBIT Margin	3.74%
FCF Margin	-1.44%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 1.56%.

Dividend Per Share	0.05
Dividend Yield	1.56%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	110.76%
Buyback Yield	n/a
Shareholder Yield	1.56%
Earnings Yield	1.41%
FCF Yield	-3.11%

Stock Splits

The last stock split was on April 6, 1995. It was a forward split with a ratio of 1.25.

Last Split Date	Apr 6, 1995
Split Type	Forward
Split Ratio	1.25

Scores

Southern Acids (M) Berhad has an Altman Z-Score of 4.37.

Altman Z-Score	4.37
Piotroski F-Score	n/a